CD4 and neoplasm: Given the increase in B16F10 tumour-infiltrating DCs, co-stimulatory molecules on DCs, and activated (CD25+, TIGIT+) CD4 T cells, we predicted DC and T cell interactions might play a role in prolonging survival in Fgl2−/− mice.